Figure 1From: Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s diseaseSubject disposition. *The completion status for one patient was not determined. †Includes all treatment emergent and treatment non-emergent AEs and SAEs.Back to article page